http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0248583-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate 1987-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01ae7e06bebdb72606bbbe95b7b76e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef85bb6e5b80b0fde61a4b171090ec76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e692f5ed622be4459b545c35d92bce34
publicationDate 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0248583-B1
titleOfInvention Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
abstract Human basal cell carcinoma is successfully treated by intralesional administration of recombinant human alpha interferon, especially interferon alfa-2b. The preparation of suitable pharmaceutical compositions is disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4019037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018178215-A1
priorityDate 1986-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11645942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID347468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135829971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983

Total number of triples: 37.